1. 输入关键词后点击检索按钮可查询指定关键词在语料中的对应情况
  2. 选择语种可限定关键词的语言,当前支持中文和英文,默认选择中文
  3. 主题选项中可限定检索语料的文章主题范围,默认全部主题
  4. 主题选项中可限定检索语料的文本类型范围,默认全部类型
  5. 在结果列表中,点击操作栏中的“查看中文全文”或“查看英文全文”按钮可查看该句所在的中文语料全文
句对齐列表 共 16269 个结果  
序号 中文 英文 操作
7981 母乳喂养的孩子在智力测验中表现较好,不太可能超重或肥胖,而且今后罹患糖尿病的几率较低。 Breastfed children perform better on intelligence tests, are less likely to be overweight or obese and less prone to diabetes later in life.
7982 哺乳妇女患乳腺癌和卵巢癌的风险较低。 Women who breastfeed also have a reduced risk of breast and ovarian cancers.
7983 然而不当销售母乳代用品继续影响在全世界努力提高母乳喂养率和持续时间。 Inappropriate marketing of breast-milk substitutes continues to undermine efforts to improve breastfeeding rates and duration worldwide.
7984 新的分析结果显示,如果基本普及母乳喂养率,每年可挽救82万名5岁以下儿童和2万名妇女的生命。 New analyses have revealed that increasing breastfeeding to near-universal levels could save the lives of more than 820 000 children aged under 5 years and 20 000 women each year.
7985 此外,若能在至少头6个月对每个婴幼儿进行母乳喂养,儿童的认知能力将会提高。 It could also add an estimated US$ 300 billion into the global economy annually, based on improvements in cognitive ability if every infant was breastfed until at least 6 months of age and their expected increased earnings later in life.
7986 考虑到这一因素以及今后预期收入的增加,估计这每年可为全球经济增添3000亿美元的收益 Boosting breastfeeding rates would significantly reduce costs to families and governments for treatment of childhood illnesses such as pneumonia, diarrhoea and asthma.
7987 世卫组织推荐使用度鲁特韦作为所有人群中治疗艾滋病毒的首选药物 WHO recommends dolutegravir as preferred HIV treatment option in all populations
7988 2019年7月22日 | 新闻稿 | 墨西哥城 22 July 2019 | News release | Mexico City
7989 根据新的收益和风险证据,世界卫生组织(世卫组织)推荐将抗艾滋病毒药物度鲁特韦(dolutegravir)作为包括孕妇和有生育潜力人群在内的所有人群的首选一线和二线治疗药物。 Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations, including pregnant women and those of childbearing potential.
7990 最初曾有研究结果显示,怀孕时使用度鲁特韦的妇女可能会造成其婴儿的神经管缺陷(导致脊柱裂等问题的大脑和脊髓天生缺陷)。 Initial studies had highlighted a possible link between DTG and neural tube defects (birth defects of the brain and spinal cord that cause conditions such as spina bifida) in infants born to women using the drug at the time of conception.